This post is sponsored by Astellas Pharma US, Inc.
Listen Up Ladies: Have you ever leaked urine? Felt like you need to pee so bad your odds of making it to the toilet in time were pretty slim? Wondered why you are peeing so much during the day? Well television host Debbie Matenopoulos is helping to shed light on some of these symptoms, which can be related to overactive bladder or OAB., Although Matenopoulos is not personally impacted by OAB, she feels it’s important to bring awareness to the topic, especially because it impacts many women in their 40s and older,1 and can be embarrassing to talk about.
Watch here as Matenopoulos talks to woman’s health expert Jo Ann Fisher, NP, and Marie, a retiree who began experiencing overactive bladder symptoms in her 50s and was later diagnosed by her doctor with the condition. It’s worth a watch!
And for more information you can also head over to this OAB treatment site: https://bit.ly/3D7y5p7
USE OF MYRBETRIQ
MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.
IMPORTANT SAFETY INFORMATION
Do not take MYRBETRIQ if you are allergic to mirabegron or any ingredients in MYRBETRIQ.
MYRBETRIQ may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. You and your doctor should check your blood pressure while you are taking MYRBETRIQ. Call your doctor if you have increased blood pressure.
MYRBETRIQ may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.
MYRBETRIQ may cause an allergic reaction with swelling of the face, lips, throat or tongue with or without difficulty breathing. Stop using MYRBETRIQ and go to the nearest hospital emergency room right away.
Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines especially thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). MYRBETRIQ may affect the way other medicines work, and other medicines may affect how MYRBETRIQ works.
Before taking MYRBETRIQ, tell your doctor about all of your medical conditions, including if you have liver or kidney problems.
The most common side effects of MYRBETRIQ include high blood pressure, pain or swelling of the nose or throat (nasopharyngitis), urinary tract infection, and headache.
For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for MYRBETRIQ® (mirabegron extended-release tablets).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
 Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011;77(5):1081-7.
 Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. American Urological Association Education and Research, Inc. 2019.
 Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep 2016;22(2):8-13